Quick Answer
Harvard Apparatus Regenerative Technology, Inc. reported Earnings Per Share Diluted of $0.67 (loss) per share for the year ending 2023.
- Harvard Apparatus Regenerative Technology, Inc. showed a decrease of -21.8% in Earnings Per Share Diluted from 2022 to 2023.
- This data is from Harvard Apparatus Regenerative Technology, Inc.'s annual report (Form 10-K), filed with the SEC on March 28, 2024.
- XBRL data for this metric is available from 2020 to 2023 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $0.07 (loss) per share | Q1 2021: $0.09 (loss) per share | Q2 2021: $0.04 (loss) per share | Q3 2021: $0.08 (loss) per share | Q1 2022: $0.20 (loss) per share | Q2 2022: $0.12 (loss) per share | Q3 2022: $0.10 (loss) per share | Q1 2023: $0.24 (loss) per share | Q2 2023: $0.19 (loss) per share | Q3 2023: $0.12 (loss) per share | Q1 2024: $0.15 (loss) per share | Q2 2024: $0.18 (loss) per share | Q3 2024: $0.12 (loss) per share.
- Over the full 4 years of available data (2020 to 2023), Harvard Apparatus Regenerative Technology, Inc.'s Earnings Per Share Diluted has declined by 21.8%.
- Historical annual values: Fiscal year 2023: $0.67 (loss) per share | Fiscal year 2022: $0.55 (loss) per share | Fiscal year 2021: $0.79 (loss) per share | Fiscal year 2020: $0.55 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: